RRAGB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.822150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.992000E-01
Normal-vs-Stage2
9.904300E-02
Normal-vs-Stage3
3.555900E-02
Normal-vs-Stage4
6.494200E-01
Stage1-vs-Stage2
1.131690E-02
Stage1-vs-Stage3
5.730400E-02
Stage1-vs-Stage4
5.262400E-01
Stage2-vs-Stage3
2.503600E-01
Stage2-vs-Stage4
4.134600E-01
Stage3-vs-Stage4
3.173800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.002600E-01
Normal-vs-AfricanAmerican
1.499390E-01
Normal-vs-Asian
1.508770E-01
Caucasian-vs-AfricanAmerican
8.052000E-01
Caucasian-vs-Asian
4.366400E-01
AfricanAmerican-vs-Asian
7.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.771610E-01
Normal-vs-Female
2.065200E-01
Male-vs-Female
6.010800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.353200E-01
Normal-vs-Age(41-60Yrs)
3.837000E-01
Normal-vs-Age(61-80Yrs)
1.118760E-01
Normal-vs-Age(81-100Yrs)
1.173900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.680300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.645940E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.428600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.300250E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.355800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.131800E-02
Normal-vs-Daily Drinker
1.958230E-01
Normal-vs-Weekly Drinker
1.183750E-01
Normal-vs-Occasional Drinker
2.656800E-01
Normal-vs-Social Drinker
3.996000E-01
Non Drinker-vs-Daily Drinker
3.503400E-01
Non Drinker-vs-Weekly Drinker
7.997800E-01
Non Drinker-vs-Occasional Drinker
2.468800E-01
Non Drinker-vs-Social Drinker
2.026800E-01
Daily Drinker-vs-Weekly Drinker
6.111400E-01
Daily Drinker-vs-Occasional Drinker
8.018800E-01
Daily Drinker-vs-Social Drinker
6.582400E-01
Weekly Drinker-vs-Occasional Drinker
4.817600E-01
Weekly Drinker-vs-Social Drinker
4.181600E-01
Occasional Drinker-vs-Social Drinker
8.365600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.991900E-02
Normal-vs-Grade 2
6.678000E-03
Normal-vs-Grade 3
9.179300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.537000E-01
Grade 1-vs-Grade 3
8.354200E-01
Grade 1-vs-Grade 4
8.991900E-02
Grade 2-vs-Grade 3
6.831000E-01
Grade 2-vs-Grade 4
6.678000E-03
Grade 3-vs-Grade 4
9.179300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.843700E-02
Normal-vs-NonDiabetic
2.137200E-01
Diabetic-vs-NonDiabetic
8.505900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.490390E-01
Normal-vs-NoPancreatitis
1.425390E-01
Pancreatitis-vs-NoPancreatitis
9.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.158400E-01
Normal-vs-N1
1.100200E-01
N0-vs-N1
4.634600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.582350E-01
Normal-vs-TP53-NonMutant
4.338400E-01
TP53-Mutant-vs-TP53-NonMutant
3.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
